Clinical Trials

Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids

Location:

Rochester, MN

Trial status:

Open for Enrollment

Why is this study being done?

Will oral supplementation with Omega 3 free fatty acids in obese Barrett's esophagus subjects downregulate pro-neoplastic and pro-inflammatory pathways in the esophagus to anti-inflammatory pathway?

Last updated: 01/15/2013

NCT ID:

NCT01733147